Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-16

Clinical Trial Update: Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum Disorders [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Tideglusib versus placebo in adolescents with Autism Spectrum Disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tideglusib (tideglusib)

Snippet

Sponsor: Holland Bloorview Kids Rehabilitation Hospital | Conditions: Autism Spectrum Disorders | Phase 2 | Status: COMPLETED